Literature DB >> 9548568

Mechanism of protein kinase CK2 association with nuclear matrix: role of disulfide bond formation.

P Zhang1, A T Davis, K Ahmed.   

Abstract

Nuclear matrix (NM) appears to be an intranuclear locale for significant and dynamic association of the ubiquitous multifunctional messenger-independent serine/threonine protein kinase CK2 that has been implicated in growth control [Tawfic et al. (1996): J Cell Biochem 61:165-171]. We have examined the nature of the association of CK2 with the NM. Nuclei prepared in the presence of a sulfhydryl-blocking reagent such as iodoacetamide demonstrate a reduction in the amount of CK2 associated with the NM to less than 5% of the control. On the other hand, when nuclei are treated with the sulfhydryl crosslinking reagent sodium tetrathionate, NM-associated CK2 increases severalfold. Treatment of nuclei with sodium tetrathionate followed by 2-mercaptoethanol blocks this increase. Nuclei isolated from rat liver and prostate behaved similarly, suggesting an identical mode of association of CK2 with the NM regardless of the organ. These results indicate a role of sulfhydryl interactions such that NM anchoring of CK2 occurs via its beta subunit, which contains several vicinal cysteine residues. Further, various sulfhydryl-blocking reagents inhibited CK2 activity in a concentration-dependent manner, and the inhibitory effect was reversed by agents such as dithiothreitol, implying that cysteine residues in the CK2 play a role in its catalytic activity.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548568

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  12 in total

1.  CK2 interacting proteins: emerging paradigms for CK2 regulation?

Authors:  Mary Ellen K Olsten; Jane E Weber; David W Litchfield
Journal:  Mol Cell Biochem       Date:  2005-06       Impact factor: 3.396

2.  CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.

Authors:  Judit Pallares; David Llobet; Maria Santacana; Nuria Eritja; Ana Velasco; Dolors Cuevas; Susana Lopez; Victor Palomar-Asenjo; Andree Yeramian; Xavier Dolcet; Xavier Matias-Guiu
Journal:  Am J Pathol       Date:  2008-12-04       Impact factor: 4.307

Review 3.  Protein kinase CK2--a key suppressor of apoptosis.

Authors:  Kashif A Ahmad; Guixia Wang; Gretchen Unger; Joel Slaton; Khalil Ahmed
Journal:  Adv Enzyme Regul       Date:  2008-04-30

4.  Role of protein kinase CK2 in phosphorylation nucleosomal proteins in relation to transcriptional activity.

Authors:  C Guo; A T Davis; S Yu; S Tawfic; K Ahmed
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

5.  Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.

Authors:  Janeen H Trembley; Gretchen M Unger; Diane K Tobolt; Vicci L Korman; Guixia Wang; Kashif A Ahmad; Joel W Slaton; Betsy T Kren; Khalil Ahmed
Journal:  Mol Cell Biochem       Date:  2011-07-15       Impact factor: 3.396

6.  Overexpressions of CK2β and XIAP are associated with poor prognosis of patients with cholangiocarcinoma.

Authors:  Fan Zhou; Jiewei Xu; Guoping Ding; Liping Cao
Journal:  Pathol Oncol Res       Date:  2013-07-05       Impact factor: 3.201

Review 7.  Protein kinase CK2 in health and disease: CK2: a key player in cancer biology.

Authors:  J H Trembley; G Wang; G Unger; J Slaton; K Ahmed
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

8.  Platelet-activating factor enhances tumour metastasis via the reactive oxygen species-dependent protein kinase casein kinase 2-mediated nuclear factor-κB activation.

Authors:  Kyoung-Jin Kim; Kyung-Deuk Cho; Kyu Yun Jang; Han-A Kim; Hae-Kyoung Kim; Hern-Ku Lee; Suhn-Young Im
Journal:  Immunology       Date:  2014-09       Impact factor: 7.397

9.  Overexpression of nuclear protein kinase CK2 α catalytic subunit (CK2α) as a poor prognosticator in human colorectal cancer.

Authors:  Kai-Yuan Lin; Chein Tai; Jung-Chin Hsu; Chien-Feng Li; Chia-Lang Fang; Hsi-Chin Lai; You-Cheng Hseu; Yi-Feng Lin; Yih-Huei Uen
Journal:  PLoS One       Date:  2011-02-17       Impact factor: 3.240

10.  Phosphorylation of apoptosis repressor with caspase recruitment domain by protein kinase CK2 contributes to chemotherapy resistance by inhibiting doxorubicin induced apoptosis.

Authors:  Jianxun Wang; Chang Feng; Yuqi He; Wei Ding; Jianqiu Sheng; Muhammad Arshad; Xiaojie Zhang; Peifeng Li
Journal:  Oncotarget       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.